Jagat Narula, MD, PhD, MACC, FRCP is Philip J. and Harriet L. Goodhart Chair in Cardiology, Chief of Cardiology, St. Luke’s & Roosevelt Hospital of Mount Sinai, Professor of Medicine and Radiology, Icahn School of Medicine at Mount Sinai. He is also Associate Dean, Arnhold Institute for Global Health at Mount Sinai. He is the Editor-in-Chief of Journal of the American College of Cardiology: Imaging, Executive Editor of Journal of the American College of Cardiology and Editor-in-Chief of the Global Heart (the official Journal of World Heart Federation).
Dr. Narula after completing his cardiology fellowship training and PhD (Cardiovascular Immunology) from the All India Institute of Medical Sciences, Delhi, relocated to Massachusetts General Hospital (MGH) and Harvard Medical School in 1989. At MGH, after cardiology, heart failure & transplantation, and nuclear cardiology fellowships and he joined the cardiology faculty. In 1997, he moved to Hahnemann University School of Medicine, Philadelphia, where he was Thomas J. Vischer Professor of Medicine, Chief of the Division of Cardiology, Vice-Chairman of the department of Internal Medicine, and Director of Heart Failure & Transplantation Center. He subsequently joined University of California, Irvine School of Medicine (2003) as Chief of the Division of Cardiology, Associate Dean for Research, and Director of the Cardiovascular Center of the UC Irvine’s Douglas Hospital. He was also the Director of Memorial Heart & Vascular Institute, Long Beach Memorial Hospital, and Medical Director of the Edwards Lifesciences Center for Advanced Cardiovascular Technology in UC Irvine’s Henry Samueli School of Engineering. He moved to Mount Sinai as the Philip J. and Harriet L. Goodhart Chair in Cardiology, and the Director of Cardiovascular Imaging Program in the Mount Sinai’s Zena and Michael A. Wiener Cardiovascular Institute in 2011.
Dr. Narula has the unique distinction of being able to combine molecular and subcellular pathology and imaging with clinical imaging of the failing myocardium and high-risk coronary atherosclerotic plaques to develop novel strategies for prevention of cardiovascular disease and promotion of cardiovascular health in developed as well as developing countries. He has specifically contributed to two major areas including heart muscle cell apoptosis in heart failure, and lipid-rich atherosclerotic plaques that are susceptible to rupture and acute coronary events. He has brought novel experimental strategies to bedside and defined their applicability at the community level. He is currently actively involved in numerous population-based heart attack prevention programs including HAPPY [Heart Attack Prevention Program for You]. Based on his expertise in global medicine, he serves on the Advisory Council on Global Prevention of Cardiovascular Diseases of the Institute of Medicine of the National Academies of Sciences.
His research has been funded, in part, by the grants from National Institutes of Health. He is considered to be a true translationist and one of the infrequent investigators who has distinction of publishing in the best basic science and the best clinical journals including Science, Nature Medicine, PNAS, New England Journal of Medicine, Lancet, Circulation and JACC. With more than 1000 original research publications or presentations to his credit and more than 35 books or journal supplements edited, Dr. Narula has been awarded as ‘the best young investigator’ on several occasions for his research contributions. His mentoring prowess is exemplified by the fact that 20 of his fellows, working in his research laboratory, have been awarded young investigator awards. He was recently awarded as the Best Educator as also the Innovator in Cardiovascular Medicine by the American College of Cardiology in the year 2012, and was honored as the Master of the American College of Cardiology in March 2013. He has just received the Distinguished Scientist Award 2015 from the American College of Cardiology.
Prof Karen Sliwa is Director of the Hatter Institute for Cardiovascular Research in Africa, Professor in the Division of Cardiology, Department of Medicine, Faculty of Health Sciences University of Cape Town, and Past President of the World Heart Federation (2019-2020). Karen Sliwa is widely recognized as a world expert in cardiovascular disease, with a particular interest in reducing mortality in women with cardiovascular disease in maternity. She has contributed to better understanding on the pathophysiology, treatment options and awareness of peripartum cardiomyopathy (PPCM), a global disease particularly prevalent in African populations. She leads several inter-Africa research projects, which have had a major impact for creating knowledge about CVDs common in Africa, leading to changes in policy. Her considerable experience in setting up simple, cost-effective registries and web-based data entry platforms have had a major impact on planning several innovative research projects and has facilitated the training of physicians from several African countries, including Mozambique, Nigeria, Cameroon, Uganda and Tanzania. Her translational research from bed-to-bench-to-bedside population studies have led to a much better understanding of CVDs in pregnant women and subsequently to improved patient care. Professor Sliwa leads several high-profile special interest groups including a dedicated EORP Working Group on PPCM of the Heart Failure Association of European Society of Cardiology. Over her distinguished career she has served in many notable roles, including that of Chair of the South African Heart Failure Association, President of the South African Heart Association (2014-2016), President of the World Heart Federation (2019-2020), and Vice President, Southern Region of the Pan African Society of Cardiology (2016-2021). She holds numerous awards such as the German Cardiac Society Paul Morawitz Award for Exceptional Cardiovascular Research (2013), an Honorary Doctorate University Diderot-Sorbonne, Paris, France (2017), European Society of Cardiology Geoffrey Rose Award for Population Sciences (2019) and the South African Medical Research Council Gold Award (2021). She has authored more than 350 publications, trained more then 30 post graduate students, and her papers are highly cited (72,270 citations; h-index of 84, i10-index 239; accessed Feb 2021).
DANIEL JOSÉ PIÑEIRO • Full Professor of Medicine, Universidad de Buenos Aires, Argentina • President-Elect, World Heart Federation • Advisor for HEARTS, Pan American Health Organization • Former President, Inter American Society of Cardiology and Argentine Society of Cardiology • Former Board of Trustees, American College of Cardiology World Heart Federation, • Former Board Member, World Heart Federation • Former Roadmaps Liaison Officer, Science Committee, World Heart Federation Prof. Daniel José Piñeiro currently is a Full Professor of Medicine at the Universidad de Buenos Aires, Argentina (2005-). He is very active in different international organizations: Trustee at the Board of Trustees of the American College of Cardiology (2018-2021), Advisor for HEARTS at the Pan American Health Organization (2018-), and Roadmaps Liaison Officer at the Science Committee of the World Heart Federation (2019-2020). Prof. Piñeiro has served twice as Member at the Board of the World Heart Federation (2011-2013 and 2017-2018), Member at Membership Committee of the American College of Cardiology (2016-2017), Chair of the Assembly of International Governors of the American College of Cardiology (2015-2017), President of the Inter American Society of Cardiology (2011-2013) and President of the Argentine Society of Cardiology (2005) He is a fellow of the American College of Cardiology, the European Society of Cardiology, and the American Heart Association. Prof. Piñeiro graduated as a physician with honors at the Universidad de Buenos Aires. He is involved in academic and educational activities as well as clinical practice. He also has a great interest in Public and Global Health as WHF Roadmaps and roundtables. He regularly presents his work at international and national conferences. He has publications including books, book chapters, and articles in international and national journals. Some of these articles are guidelines, consensus, white papers, and roadmaps devoted to Global Health. He deserved 8 national and international awards.
John Kelly has broad experience in clinical, management and leadership roles across the health sector. John was appointed Group CEO of the National Heart Foundation of Australia in August 2016. John commenced his health career as a cardiothoracic nurse specialist. After graduating in Organisational Psychology and Law, John worked in various health organisations, non-profit entities and the law. John was a health law partner for 15 years at leading top 10 legal practices in Australia.
Immediately prior to his role at the Heart Foundation, John served for four years as CEO of Aged & Community Services Australia, which represented the church and charitable sector in the $9b retirement living and aged care sector.
John has extensive experience on non-profit boards, including time as Chair of large Australian charities, The Smith Family as well as the Royal College of Nursing Australia and Uniting Care Ageing (NSW & ACT). His international experience includes representing Australia on the International Council of Nurses.
John holds academic appointments with the Sydney Nursing School at University of Sydney and the Faculty of Health at the University of Technology, Sydney (UTS).
In 2009 John was named a Member of the Order of Australia (AM) and received the Alumni Award for Excellence from UTS. In 2010 John was appointed by the Federal Government as Commonwealth Aged Care Commissioner. In 2019 John was awarded a Distinguished Life Fellow with the Australian College of Nursing.
General Secretary, Swedish Heart Lung Foundation, 20141001 – ongoing
Assistant Secretary General, Heart-Lung Foundation, 2012 – 2014
Support the GS in business development. Creating commitment and consensus on business and brand and communications platform internally and externally. Ensure that Board decisions are implemented by operational lead efforts to develop and implement the overall strategy and plans for the business. Ensure revenue targets.
Fundraising and Marketing Manager, The Swedish Heart-Lung Foundation, Stockholm, October 2004 – 2014
Overall responsible for the strategy which aims to develop the business total revenue (collection), marketing and brand awareness.
Results for the first 8 years is a revenue increase from 70 million to about 234 million / per year (see picture below). A revenue increase of about 20 percent per year. The main tasks are to take responsibility for the brand, marketing and communication, advertising and marketing initiatives, product ie all revenue channels and loyalty strengthening efforts sensors (clients). Responsible for revenue and cost budget. Dense relationship with agencies, partners, suppliers, directors, researchers and European colleagues. Personnel included in the service of about 20 people and two group leaders. Member of the management.
Fundraising Manager, The Swedish Heart-Lung Foundation, Stockholm, August 1999 – October 2004
Developed a basis for the existing collection and marketing efforts. Implemented methods DR, TM and requirements posed new computer system for the collection business. Responsible for the customer – and exhibition activities.
Budgetary and supervisory responsibility for about four people. Contact with clients and advertising agencies, printers, agents, agencies Etc.
Project manager and coordinators, The Swedish Heart-Lung Foundation, Stockholm,
August 1996 – August 1999. Start-up and establishment of a new international health project in Sweden; Health Path. In cooperation with the municipalities establish specific walking trails to the public in order to increase the daily exercise for everyone. Today there are about 80 loops.
Coordinator of the exhibition activities and events and to the Fund volunteering.
District Manager Janne Class AB, Stockholm, Sales Manager for Mälardalen. November 1995 – July 1996. Sales of all products to opticians and its workshops excl frames and lenses. Travel service with client meetings and largely phone contact.
District Manager, IMMOBILIZER AB, Stockholm, August 1995 – November 1995. Responsible seller immobilizer system for motor vehicles to dealers and workshops.
Sales through its own pre-booked meetings with customers.
Teachers, Spånga Gymnasium, Stockholm, September 1992 to June 1995 Fittjaskolan, Stockholm, January 1989 – June 1991 and January 1987 – June 1987 Resource Teachers in Swedish, electrical / telecommunications engineering, English and mathematics for grades 7-9 and high school students ride first
Communicative, curious, driven and innovative.
Lindberg & Göthberg, Executive senior program, 2015 – 2017
Stockholm School of Economics IFL Executive, 2012- 2013
LPU, leadership through personal development
Executive MBA from Stockholm University School of Business at the Department of Business Administration, Executive MBA 2 years
EMBA Stockholm, 2010 – 2012
– Financial Statisment Analysis
– Strategy in Practice and Marketing Management –
Corporate Social Responsibility
– Change management
– Global Cross Cultural Business Behavior
– Ethical leadership
– Corporate Governance
– Essay – Does the SFC-code support donor’s interest?
IHM MASTER 1.5 years 2005-2007
DIHM, Operations Management
DIHM, Business Development
DIHM, Personal Leadership
DIHM, Business Communication, 2 years 2001-2003
– Business Acumen, Module 1
– Business of Communication grounds, Module 2
– Communication management and change instruments, Module 3
– The company’s reputational capital, Module 4
– Communication with the market, Module 5
– Shareholders thesis, Module 6
3-year technical school Brännkyrka and Åsö School, 1984-88
Swedish Pharmaceutical Society, board member 2018- ongoing
Research Sweden, board member 2015 – ongoing
King Oscar the II jubilee foundation, board member 2014- ongoing
The Swedish Fundraising Council (SFC), board member 2012-2018
The Swedish Fundraising Council European certification training (EFA) for fundraisers at Berghs School of Communications, 2009 – ongoing
The Swedish Fundraising Council Volunteer Fundraising., Course Leader for FRII’s annual course in collection, 2007- 2014
Swedish Fundraisers; board member 2004 – in 2008. Non-profit association for the industry fundraisers (collector) with a mandate to pursue knowledge between different fundarisers.
Engaged as a lecturer at the example:
– Bonnierförlagen AB
– European Heart Network,
– DR Academy
– Berghs School of Communication
– SFC seminar, NGO Fundraising
Swedish – Native. Fluent spoken and written
English – Good command of spoken and written.
Álvaro Avezum, cardiologist and epidemiologist, is the Director of the International Research Center at Oswaldo Cruz German Hospital and Research Director of São Paulo State Society of Cardiology in São Paulo, Brazil, Professor at São Paulo University and UNISA, International Research Associate at Population Health Research Institute, McMaster University, and elect World Heart Federation At Large Member. He received his medical degree from the Federal University of Triângulo Mineiro, MG, Brazil, in 1985; completed his residency in Internal Medicine, followed by the completion of 3-year residency in cardiology, at Dante Pazzanese Institute of Cardiology in São Paulo, in 1990; did research fellowship training in cardiology and earned an MSc in Clinical Epidemiology at McMaster University, Hamilton, Canada, from 1993 to 1995; and obtained his PhD in Cardiology from São Paulo University in 2002 and professorship at CardioPneumology Department, São Paulo University in 2016. His previous positions at Medical Societies in Brazil include: São Paulo Cardiology Society (Vice-President and Scientific Director) and Brazilian Cardiology Society (President, Cardiovascular Health Promotion- Funcor, President, Evidence-Based Cardiology Committee, President Spirituality and Cardiovascular Medicine Committee), InterAmerican Cardiology Society (Coordinator, Epidemiology Chapter) World Heart Federation (Member of the Cardiovascular Secondary Prevention Committee), and Research Director at Dante Pazzanese Institute of Cardiology . Dr. Avezum´s selected contributions include the introduction and cardiologist´s training of evidence-based medicine, capacity building and clinical trials, epidemiological studies coordination, clinical practice evaluation and improvement in cardiovascular disease, and the cardiovascular health promotion initiative in Brazil. His main research interests include clinical trials in cardiovascular diseases, evidence-based practice, cardiovascular disease prevention, epidemiological studies, systematic overview, and knowledge translation interventions. Dr. Avezum has been a steering committee member of 70 studies (randomized clinical trials and epidemiological studies), adjudication committee member of more than 30 studies, and author/co-author of 252 peer-reviewed published scientific papers, including key articles in high impact journals. h-Index of 82 (Nov, 2019). He has been a reviewer of AHJ, AJC, EHJ, Circulation, JACC and Lancet. Recently, he was identified as one of the world´s most influential scientific minds, 2014 and 2015, in clinical medicine, by Thompson Reuters, and by Clarivate Analytics in 2019.
Professor Junbo Ge is academician of Chinese Academy of Sciences; the chief of cardiology department of Zhongshan Hospital, Fudan University; the chief of Shanghai Cardiovascular Clinical Center; the chairman of Shanghai Institute of Cardiovascular Diseases; the head of Institutes of Biomedical Sciences;the head of Institute for Pan vascular Medical Research, Fudan University;the chairman of Pan vascular Fund, Fudan University; director of Engineering Research Center for Cardiovascular Devices, Ministry of Education; He was awarded Scholars of the Yangtse River; Elite of science and technology; National Labor Medal; Tan Jiazhen prize in life sciences; the national “Bethune” Medal, etc. He is also the president of the Chinese Society of Cardiology; the chairman of China Cardiovascular Association; board member of The Society for Cardiovascular Angiography and Interventions; member of the international advisory board of American College of Cardiology. Prof. Ge dedicates to the optimization and innovation of diagnosis and treatment strategy for coronary artery disease and made extraordinary achievements in intravascular ultrasound (IVUS). His research areas also includes development of novel coronary stents, treatment strategy optimization of complex CAD and stem cell therapy. Prof. Ge has been responsible for over 20 scientific research projects supported by the government, Furthermore, a total of over 300 papers published by Prof. Ge have been included by SCI-E (as the first author or the corresponding author). Prof. Ge has edited 20books (one published abroad) and co-edited more than 20 monographs and textbooks. He is the chief editor of Internal Medicine (8th edition), Practice of Internal Medicine (15th edition), Cardiology Plus and deputy editor of Herz. As the first person to complete a project, Prof. Ge has received more than fourteen awards, including the second prize of National Award for Science and Technology Progress, the second prize of National Award for Technological Invention, the first prize of Science and Technology Progress Award presented by the Ministry of Education, the second prize of the China Medical Technology Award(twice),the first prize of the Shanghai Science and Technology Progress Award, etc.
Dr. Mbakwem is a professor of Medicine at the University of Lagos and a consultant cardiologist to the Lagos University Teaching Hospital. She completed her residency training in internal medicine and cardiology at the Lagos University Teaching Hospital and received a Fellowship of the West African College of Physicians. She underwent further training in cardiology at the Wolfson Heart Institute in Tel Aviv, Israel and Azienda Sanitaria, Tuscany, Italy. Dr Mbakwem’s research interest includes Heart failure, systemic and pulmonary hypertension, heart disease in women, effective communication in disease management and the psychosocial issues in cardiovascular diseases. She is a member of the Nigerian Hypertension society guidelines writing committee. She is the immediate past President of the Nigerian Cardiac Society and a member of the European Society of Cardiology working group on Peripartum cardiomyopathy. She is the treasurer of PASCAR
Legal, communications/social media, fundraising
Master of Law (MKn) / Universitas Indonesia / 2004
Bachelor of Law (SH) / Universitas Indonesia / 1991
World Heart Federation
Board Member 2021 – present
Aliansi Penyakit Tidak Menular (NCD Alliance)
Chairman 2021 – present
Indonesia Heart Foundation
Chairman 2018 – present
Owner/Director 2006 – present
Indonesia Heart Foundation
Head of Funds Development 2016 – 2018
Indonesia Heart Foundation
Information and Communication Officer 2009 – 2016
Lubis Ganie & Surowidjojo Law Firm
Associate lawyer 1995 – 1996
Alejandro Ramos Carbajales is an Independent consultant and researcher in tobacco tax and other health policies, demand for tobacco products, Illicit tobacco trade. Background in the economic evaluation of health policies and reform and cost effective analysis of investment in health infrastructure for the IDB and World Bank as a part-time consultant.
Liesl Zühlke, MBChB DCH FCPaeds Cert Card MPH FESC FACC PhD trained as a Paediatric Cardiologist in Cape Town and Dusseldorf, Germany. She has a MPH in clinical research methods, and her doctorate at the University of Cape Town provided new insights on outcomes of symptomatic and asymptomatic Rheumatic Heart Disease.
Prof Zuhlke is widely regarded as an emerging leader in cardiovascular medicine on the African continent. Her major research interests lie in Rheumatic Heart Disease and congenital heart disease. A paediatric cardiologist in the Dept of Pediatric Cardiology at RXH, she worked as the clinical co-coordinator of the ASAP programme, managing several large scale RHD projects in South Africa and on the African continent. In this capacity, she was instrumental in the development, coordination and management of the largest prospective RHD registry the Rheumatic Heart Disease Registry (the REMEDY study) involving 25 sites, in 12 African countries, Yemen and India and is currently the national leader of the INVICTUS study, which aims to enrol over 30 000 RHD patients.
She has received a number of awards including an academic excellence award from Discovery, NIH Fogarty Fellowship, Wellcome CIDRI and Thrasher awards and the Hamilton Naki Post-doctoral Clinical Scholarship, an award given to clinical scholars of excellence. She is the immediate past president of the pediatric cardiac society of South Africa, President of the South African Heart Association and the chairperson of the Pan African Society of Cardiology Paediatric Cardiology and Cardiac Surgery Task force. She was one of the organizers of the 6th World Congress of Paediatric Cardiology and Cardiac Surgery 2013, the World Congress of Cardiology and Cardiovascular Health 2016 and is on the organising committee for the World Congress of Paediatric Cardiology and Cardiac Surgery in 2017. A previous board member of the Heart and Stroke Foundation of South Africa, she is now on the board of the Hatter Institute for Cardiovascular Research and is co-director of Rheach (Rheumatic Heart Disease-Evidence, Advocacy, Communication and Hope), the recipient of one of the largest grants from Medtronic Philanthropy for work in Rheumatic heart disease. The initiative will be providing scientific and technical support for Global RHD programmes over the next five years.
Barbara Casadei is a British Heart Foundation (BHF) Professor of Cardiovascular Medicine at the University of Oxford and Honorary Consultant Cardiologist at the Oxford University Hospitals NHS Trust where she leads the Cardiovascular Theme of the National Institute for Health Research (NIHR) Biomedical Research Centre and is a Steering Committee member of the BHF Centre of Research Excellence.
Barbara graduated in Medicine (cum Laude) at the University of Pavia, Italy which awarded her the Medaglia Teresiana for academic merit, and moved to Oxford in 1989 to undertake her clinical and research training. She was awarded the Joan and Richard Doll Fellowship at Green College in 1991, a DPhil in Cardiovascular Medicine in 1995, and a BHF Senior Research Fellowship in 2001. She is a Fellow of the UK Academy of Medical Sciences, holder of the highest honour of the British Cardiovascular Society (The Mackenzie Medal), and Immediate Past President (2020-22) of the European Society of Cardiology.
As Vice-President of the ESC, she established the Women in the ESC (WinESC) initiative, was responsible for the Society’s 5-yr Strategic Plan on Research, and initiated a partnership with the National Initiative on Gender, Culture and Leadership in Medicine, Brandeis University, US, and with the Said Business School of the University of Oxford (The Women Transforming Leadership Programme). As President of the ESC, she obtained the ESC Board’s support to start the ESC Patient Forum https://www.escardio.org/The-ESC/What-we-do/esc-patient-engagement, whose members are now contributing to most ESC activities, and EuroHeart, an initiative supporting the assessment and improvement of quality of cardiovascular care in Europe https://doi.org/10.1093/eurheartj/ehz599.
She provides a clinical service at the Oxford University Hospitals NHS Trust’s John Radcliffe Hospital and leads a bench-to-bedside translational research programme, which spans from bench-based investigation in human tissue and cells to clinical trials.
Richard A. Chazal, MD, MACC
Rick Chazal is a senior cardiologist and the Medical Director of the Heart and Vascular Institute for Lee Health, a four hospital, not-for-profit system in Fort Myers, Florida. Dr. Chazal is the Past President of the American College of Cardiology. He has practiced clinical cardiology in Fort Myers since 1983 with expertise in echocardiography, diagnostic catheterization and coronary computerized tomography angiography. During his tenure, he has been a participant in multiple clinical trials.
Chazal received his undergraduate degree from the University of Florida and went on to complete medical school and Internal Medicine training at the University of South Florida. Subsequently, Chazal completed a fellowship in Cardiovascular Disease at the Krannert Institute of Cardiology at Indiana University, where he spent one year working under Harvey Feigenbaum, MD, FACC as a designated echocardiography fellow.
Chazal served as councillor, treasurer and president of the ACC’s Florida Chapter. Subsequent to his stint as president and governor for the Florida Chapter, he was elected Chair of the ACC Board of Governors. He has also been ACC Treasurer and Chair of the Budget and Finance Committee. In combined capacities, Chazal has spent thirteen years on the ACC Board of Trustees. Nationally, Chazal has served as a member and/or chair of over 50 committees and workgroups for the College.
He is a member of Alpha Omega Alpha and Omicron Delta Kappa honoraries through the University of South Florida. He is the recipient of multiple awards from the ACC Florida Chapter, including the Special Achievement Award, the Presidential Citation, the Distinguished Service Award, and the Founder’s Award. In 2011, the Southwest Florida Affiliate of the American Heart Association awarded him their Golden Heart Award, and in 2014 he was designated Distinguished Fellow of the American College of Cardiology. He received the inaugural Community Teaching Award from the Family Medicine Residency Program via Florida State University School of Medicine Fort Myers Program in 2015. The Lee County Medical Society honored Chazal with the Lifetime Achievement Award in 2017. He serves as courtesy assistant professor of medicine for the University of Florida and clinical associate professor of medicine for Florida State University.
He and his wife Linda have three children and three grandchildren.
Dr. Mark A. Creager, MD, FAHA, FACC, is the Anna Gundlach Huber Professor of Medicine and Professor of Surgery at the Geisel School of Medicine at Dartmouth, and he is Director of the Heart and Vascular Center at Dartmouth-Hitchcock Medical Center in Lebanon, NH. Dr. Creager earned his medical degree at Temple University in Philadelphia. He completed his internship, medical residency, and fellowships in Vascular Medicine and Cardiology at University Hospital in Boston.
Dr. Creager is a Past President of the American Heart Association and served on its National Board of Directors. He is an editor of the textbook, Vascular Medicine and the editor emeritus of the journal, Vascular Medicine. He is a Past President of the Vascular Disease Foundation, and a Past President and Master of the Society for Vascular Medicine. He is a Fellow of the American Heart Association and of the American College of Cardiology, and a member of the American Society of Clinical Investigation. His major research and clinical interest is in vascular medicine, specifically vascular regulatory mechanisms and the effect of treatment on patients with peripheral artery disease. He is the author of more than 400 published contributions to the medical literature, including: research papers on vascular function, book chapters, and monographs on vascular disease. Dr. Creager has been recognized with several prestigious awards and honors, including the American Heart Association Distinguished National Leadership Award and the Vascular Disease Foundation President’s Award for Leadership.
As a member of the InterAmerican Heart Foundation, Beatriz is dedicated to the prevention and control of non-communicable diseases or NCDs, heart diseases and stroke in the Americas. She helped found her organization and was Executive Director from 1995 to 2017. She continues her active engagement with a focus on advocacy.
Beatriz’s contributions include advocacy to promote and defend policies supporting good nutrition, physical activity, control of tobacco and alcohol. She organized and has led the Healthy Latin America Coalition (CLAS) that has more than 300 member organizations in the region and has been instrumental in presenting a coherent response from civil society to issues arising nationally and internationally. She advocates for salt reduction in the region as part of the “Scaling up Salt Reduction Consortium.”
In tobacco control she set up the first tobacco control virtual network in Latin America and a separate one in the Caribbean. She organized many capacity building workshops to promote effective tobacco control policies including smokefree environments and tobacco warning labels. She supported tobacco warning labels research in the Caribbean and Central America resulting in a compendium of tested well-tailored warning labels for this region. She organized 7 journalism contests and awards. In smoking cessation, Beatriz worked to implement WHO guidelines including supporting national planning, training and networking of health professionals. She was a Principal Investigator of the CARMELA study of CV risk factor prevalence in seven Latin American cities; and co-Principal Investigator of the NIH funded “From production to retailing: policy-oriented research on tobacco economy in Argentina.” Beatriz was president and main organizer of five Latin American and Caribbean Tobacco or Health Conferences that took place in Rio de Janeiro; Mexico City; Lima, Peru; San Jose, Costa Rica; and Montevideo, Uruguay. She also supported economic studies in Central America in preparation for tobacco taxation.
Her organization received the 2009 Luther L. Terry Awards for Exemplary Leadership in Tobacco Control. The CLAS coalition received the 2017 Sharjah Award for Excellence in NCD Civil Society Action for its initiative “Rapid Regional Response to Strengthen and Defend National NCD Policies”. More recently she received the 2018 WHO World No Tobacco Day Award.
She holds a Master of Science and Ph.D. from Rutgers University, New Brunswick, New Jersey, and a Bachelor of Science summa cum laude from the University of Illinois at Champaign-Urbana. She was born and spend her formative years in Buenos Aires, Argentina.
Professor of Clinical Epidemiology, University Medical Center Utrecht
Rick Grobbee, is founder of the Julius Center for Health Sciences and Primary Care (1996), a division of the University Medical Center Utrecht (UMCU) currently employing approximately 500 staff, and of Julius Clinical (2008), a full service Academic Clinical Research Organization. He currently acts as the chair of the Center for Circulatory Health at the UMCU governing cardiovascular patient care, research and education. Previous positions include Professor of Clinical Epidemiology at Erasmus University Rotterdam, member of the board of Erasmus University Medical Center, and visiting Associate Professor at Harvard University, Boston. He holds honorary appointments in Sydney and Kuala Lumpur. He has been a (principal) investigator in many large-scale epidemiologic studies and randomized intervention trials relating to the prevention and treatment of cardiovascular, cardiometabolic, and cardiorenal disease. In addition he works on the principles and methods of treatment research, trial design and data analysis. He is listed in the top 100 global most influential biomedical researchers (Eur J Clin Invest 2013 Dec;43(12):1339-65) and has consistently been ranked as highly cited author by Web of Science over the last decades. Rick Grobbee has been on the editorial boards of several journals and (inter) national scientific, search, and site-visit committees. Current journal roles include senior consulting editor of the European Journal of Preventive Cardiology of which he served as editor-in-chief for eight years. He is past-president of the European Association for Preventive Cardiology and member of the board of the European Society of Cardiology. In 2010 he was appointed Distinguished University Professor of International Health Sciences and Global Health at Utrecht University. Rick Grobbee is fellow of the Royal Dutch Academy of Sciences and served as the chair of its Medical Section and Advisory Council for the Medical Sciences. He is honorary fellow of the Indonesian Heart Association and of the Romanian Society of Cardiology. In recent years his attention has increasingly been directed towards global circulatory health. In 2017 he was knighted by the Dutch King (Knight in the Order of the Dutch Lion). To date, Prof. Grobbee has authored or co-authored over 1,300 scientific papers (PubMed), chapters, and books, and has supervised more than 140 PhD fellows. His Hirsch index (Web of Science) is 146.
Professor D. Prabhakaran is a cardiologist and epidemiologist by training. He is an internationally renowned researcher and is currently the Vice President- Research & Policy, Public Health Foundation of India, Executive Director of Centre for Chronic Disease Control, New Delhi, India and Professor (Epidemiology) London School of Hygiene and Tropical Medicine, UK. He heads the Centre for Control of Chronic Conditions at PHFI which is a joint initiative of four leading institutions (Public Health Foundation of India, London School of Hygiene and Tropical Medicine, All India Institute of Medical Sciences, New Delhi and Emory University). This centre conducts cutting edge research in the prevention of chronic diseases in India and the developing world.
His work spans from mechanistic research to understand the causes for increased propensity of cardiovascular diseases (CVD) among Indians, to developing solutions for CVD through translational research and human resource development. Prof. Prabhakaran is a Fellow of the Royal College of Physicians, UK, Fellow of the National Academy of Sciences, India, and an Adjunct Professor at the Emory University. He is member of Executive Council of the International Society of Hypertension (ISH) and Chair of the International Society of CVD Epidemiology and Prevention (ISCEP). He has received funding from NHLBI, Wellcome Trust, European Commission and several other international and national funding bodies. He has mentored over 50 post-doctoral and doctoral students so far. He has authored several chapters and over 500 scholarly papers with an H index of 97. Listed as the topmost researcher in Medicine in India terms of publications for the years 2009-2014 by Scopus and Department of Science & Technology, Government of India. He is the lead editor of the Cardiovascular Disease Volume of the latest Disease Control Priorities Project. He is the lead editor of Tandon’s text book of Cardiology a two volume comprehensive book on Cardiology for Indian Cardiologists and Fellows.
Thomas A. Gaziano M.D., M.Sc. is an Associate Professor of Medicine at Harvard Medical School in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital (BWH). He is Director of Global Health and Economic Evaluations within Cardiovascular Innovations at BWH where he evaluates prevention programs in clinical services. He is currently a principal or co-principal investigator on three NIH-funded grants in Argentina and South Africa, the main focus of which are the implementation of effective cardiovascular therapies or policies in low-income settings. His Harvard CVD PREDICT model is used to evaluate health outcomes, financial impacts, and the cost-effectiveness of CVD intervention strategies. He serves on the Board of the World Heart Federation.
Jeehan Mahmood is reputed for her contribution to civil society, torture prevention social work, education and human rights. In recent years she has been working as a human rights consultant nationally and internationally. Working as the national consultant she has developed and authored the National Elderly Policy and Action Plan, The Gender Equality Policy and the Gender Equality Action Plan.
Jeehan has taught Psychology, Counselling, Research Methods, Conflict Resolution, Employment Law, Educational Leadership, Human Rights and Journalism and Mental Health in several colleges and the Maldives National University.
In 2017, she was appointed as one of the members of the fact finding mission on the Situation of Rohingya Muslims where she fulfilled her duties in the Rohingya Refugee Camps on the border of Bangladesh. The report from this mission has been published and is being used for advocacy of rights of Rohingya Muslims.
She has worked with the Human Rights commission of the Maldives (HRCM), first as a member of staff in 2008 and later as a Commissioner with particular responsibilities for torture monitoring and prevention, legal matters and policy development. She is a person with outstanding human rights expertise and experience who has shown effectiveness, dedication and courage in her work.
During her years with the HRCM she has acquired comprehensive knowledge of international human rights law and practice. She has had responsibility of taking the international norms and applying them to the day to day situations of the Maldives and its people. She has had to undertake the full range of functions of a Human Rights Commissioner, from investigation of violations to human rights education and promotion, research, monitoring and proposing amendments to existing and draft laws and policies.
Initially, as a staff member of the HRCM, she headed the unit responsible for monitoring the Maldives’ performance of its obligations under the Convention Against Torture and its Optional Protocol and later she continued her intense engagement in that work as Commissioner. This required visits to prisons and other places of detention, interviewing detainees and officials, conducting inspections, providing advice and training, preparing analytical reports and advocating for improved performance. She has also played an instrumental role in drafting and ensuring the passage of the Maldives anti-torture law through the parliament and its subsequent ratification. She was also appointed as one of the Torture Prevention ambassadors by the Asia Pacific Forum for Human Rights Institutions in 2014.
Because of her international reputation in this field, Jeehan was invited to join the board of one of the foremost international human rights organisations for torture prevention, the Association for the Prevention of Torture, a non-government organisation based in Geneva, Switzerland.
She is currently the Parliament Member for Hinnavaru Constituency and also the Chair of the parliamentary standing committee on Human Rights, Child Protection and Gender.
She is also currently doing her PhD, at the Management and Science University Malaysia, where her thesis is on access to education for children with disabilities.
Professor Evgeny Shlyakhto is a General Director of the Almazov National Medical Research Centre (Saint-Petersburg. Russia) and President of the Russian Society of Cardiology. He also serves as the Head of Department of Internal Medicine at the Pavlov First St.Petersburg State Medical University, his alma mater. In 2002 Prof. Shlyakhto took the position of the Chief Cardiologist of Saint-Petersburg and North-Western Region of Russia, and in 2018 he became the Chief cardiologist of the Russian Ministry of Health for the Volga, Southern, North Caucasian and Northwestern federal districts. His main professional interests are AI, telemedicine and precision medicine, and major research interests are laying in the area of epidemiology, prevention and treatment of hypertension, acute coronary syndrome, heart failure and atherosclerosis.
Professor Yong HUO is currently the Professor of Department of Cardiology at Peking University First Hospital, Vice President of Chinese Cardiovascular Association (CCA), President of Asian Society of Cardiology (ASC), and President of World Association of Chinese Cardiologist (WACC).
As specialist in cardiovascular medicine and Past President of Chinese Society of Cardiology, Professor Huo has made outstanding contributions to the national cardiovascular and cerebrovascular disease prevention and control.
Prof. Huo has particular clinical interests in prevention of cardiovascular diseases especially in Interventional Cardiology. He has high reputation in the area of coronary interventional treatment, and contributes to the popularization, standardization and development of cardiovascular intervention in China. Prof. Huo is in charge of national PCI registry and STEMI care network construction in China. He established the whole system of China Chest Pain Center accreditation, promoted regional STEMI care network construction in China, and has led many national funding projects on coronary heart disease.
Professor Huo’s another major research and clinical interest is stroke primary prevention in hypertensive patients and takes an international leading position. He demonstrates that one of the most important reasons for high stroke incidence in China is hypertension with elevated homocysteine level, and then confirmed that antihypertensive medication combined with folic acid supplementation, a new, simple and effective treatment strategy for stroke prevention, could reduce additional 21% stroke risk. Due to that, he won the second award of China Scientific and Technological Progress.
As the leader of the Training Center of Interventional Cardiology in Chinese Medical Association, the director of the Center for National medical quality control of cardiovascular disease (coronary intervention), and the president of Expert Committee on cardiovascular intervention training in China, Professor Huo is leading the construction of national cardiovascular disease quality control and specialist training and certification system. He leads to develop a number of national standards for disease diagnosis and treatment, guidelines and consensus of cardiovascular disease.
Professor Huo has led serial national funding projects of coronary heart disease and hypertension. His research has been widely published in over 150 leading peer-reviewed medical journals such as JAMA and JACC with IF over 650. He has also developed 68 academic monographs on interventional cardiology and cardiovascular medicine. Additionally, he had 6 patents of invention and won the second award of the Scientific and Technological Progress of the State twice and several other awards.
|cookielawinfo-checbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|